id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-0002-0070,FDA,FDA-2015-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Changes of
Sponsorship",Rule,Correction,2016-04-01T04:00:00Z,2016,4,2016-04-01T04:00:00Z,,2016-04-01T14:05:18Z,C1-2016-07135,0,0,0900006481f0947b
FDA-2015-N-0002-0069,FDA,FDA-2015-N-0002,"FONSI for sN 141-361, approved December 7, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:15:00Z,,0,0,0900006481ee9519
FDA-2015-N-0002-0067,FDA,FDA-2015-N-0002,"FOI Summary for sN 141-361, approved December 7, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:37Z,,0,0,0900006481ee9517
FDA-2015-N-0002-0063,FDA,FDA-2015-N-0002,"EA for oN 141-453, approved December 8, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:13:05Z,,0,0,0900006481ee8c48
FDA-2015-N-0002-0062,FDA,FDA-2015-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Changes of
Sponsorship",Rule,Final Rule,2016-03-30T04:00:00Z,2016,3,2016-03-30T04:00:00Z,,2016-03-30T20:48:32Z,2016-07135,0,0,0900006481eea5dc
FDA-2015-N-0002-0066,FDA,FDA-2015-N-0002,"FOI Summary for sN 141-258, approved December 2, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:24Z,,0,0,0900006481ee9516
FDA-2015-N-0002-0068,FDA,FDA-2015-N-0002,"FONSI for  oN 141-453, approved December 8, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:49Z,,0,0,0900006481ee9518
FDA-2015-N-0002-0064,FDA,FDA-2015-N-0002,"EA for sN 141-361, approved December 7, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:13:53Z,,0,0,0900006481ee8c49
FDA-2015-N-0002-0065,FDA,FDA-2015-N-0002,"FOI Summary for oN 141-453, approved December 8, 2015",Supporting & Related Material,Background Material,2016-03-30T04:00:00Z,2016,3,,,2016-03-31T13:14:12Z,,0,0,0900006481ee9515
FDA-2015-N-0002-0060,FDA,FDA-2015-N-0002,Conditional Approval of a New Animal Drug No Longer in Effect; Masitinib,Rule,Final Rule,2016-01-21T05:00:00Z,2016,1,2016-01-21T05:00:00Z,,2016-01-21T16:13:22Z,2016-01100,0,0,0900006481e24805
FDA-2015-N-0002-0061,FDA,FDA-2015-N-0002,Conditional Approval of a New Animal Drug No Longer In Effect: Masitinib Mesylate Tablets,Notice,Notice of Termination,2016-01-21T05:00:00Z,2016,1,2016-01-21T05:00:00Z,,2016-01-21T16:31:41Z,2016-01104,0,0,0900006481e2489d